PLANO, Texas--(BUSINESS WIRE)--VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for computer-aided detection (CAD) for digital breast tomosynthesis (DBT). The CAD system is designed to use VuCOMP proprietary computer vision algorithms (M-Vu Algorithm Engine) to identify areas of mammograms consistent with breast canc